Developing a blood test for cancer
The Californian healthcare company GRAIL Inc is sponsoring a research program to detect cancer early, led by Hebrew University Professor Yuval Dor. The program will analyze fragmented DNA in the bloodstream that derives from tumors, to identify the type of cancer responsible.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink